Literature DB >> 89106

Purification of a human prostate specific antigen.

M C Wang, L A Valenzuela, G P Murphy, T M Chu.   

Abstract

Rabbit antiserum raised against the crude extract of normal human prostatic tissue contained antibodies to a prostatic tissue-specific antigen as shown by immunoprecipitation techniques. Using this antiserum a prostate antigen was detected in normal, benign hypertrophic, and malignant prostatic tissues, but not in other human tissues. The prostate antigen was purified to homogeneity from prostatic tissues and showed a single protein band on analytical polyacrylamide gel electrophoresis and isoelectric focusing. This report thus presents the first demonstration of the purification of a prostate-specific antigen that does not represent prostatic acid phosphatase.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 89106

Source DB:  PubMed          Journal:  Invest Urol        ISSN: 0021-0005


  140 in total

1.  Expression and characterization of trypsinogen produced in the human male genital tract.

Authors:  A Paju; A Bjartell; W M Zhang; S Nordling; A Borgström; J Hansson; U H Stenman
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 2.  A history of prostate cancer treatment.

Authors:  Samuel R Denmeade; John T Isaacs
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

3.  IMPORTANCE OF PROSTATIC SPECIFIC ANTIGEN (PSA) IN CLINICAL PRACTICE : OUR EXPERIENCE.

Authors:  G S Chopra; R K Bindal; S V Kotwal; R Rai; J R Bhardwaj
Journal:  Med J Armed Forces India       Date:  2017-06-26

4.  Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology.

Authors:  A P Soler; G D Harner; K A Knudsen; F X McBrearty; E Grujic; H Salazar; A C Han; A A Keshgegian
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 5.  Morphologic and regulatory aspects of prostatic function.

Authors:  G Aumüller
Journal:  Anat Embryol (Berl)       Date:  1989

6.  Detection of tumor-associated membrane proteins in prostate and bladder carcinomas by means of protein blotting.

Authors:  S A Ford; P J Russell; M Jelbart; D Raghavan
Journal:  Urol Res       Date:  1989

7.  Synergistic effects of combination therapy employing antisense oligonucleotides with traditional chemotherapeutics in the PC-3 prostate cancer model.

Authors:  Paulus Tsui; Marvin Rubenstein; Patrick Guinan
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

Review 8.  mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer.

Authors:  Steffen Rausch; Christian Schwentner; Arnulf Stenzl; Jens Bedke
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  Does prostate specific antigen density correlates with aggressiveness of the prostate cancer?

Authors:  S Saidi; V Georgiev; S Stavridis; D Petrovski; S Dohcev; L Lekovski; Z Popov; S Banev; G Spasovski
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

Review 10.  New horizons in prostate cancer imaging.

Authors:  Gregory Ravizzini; Baris Turkbey; Karen Kurdziel; Peter L Choyke
Journal:  Eur J Radiol       Date:  2008-11-07       Impact factor: 3.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.